insights_auto
Why is ACAD up 3.36%?
Dive Deeperchevron_right
ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$18.75
arrow_upward
+3.36%(+0.61) 1D
$18.79
arrow_upward
+0.21% (+0.039)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$18.12
High
$18.76
Low
$18.00
Mkt. cap
3.24B
Avg. vol.
2.45M
Volume
1.79M
P/E ratio
8.94
52-wk high
$30.96
52-wk low
$15.86
EPS
$2.10
Beta
0.87
Shares outstanding
172.83M
No. of employees
797
Open
$18.12
High
$18.76
Low
$18.00
Mkt. cap
3.24B
Avg. vol.
2.45M
Volume
1.79M
P/E ratio
8.94
52-wk high
$30.96
52-wk low
$15.86
EPS
$2.10
Beta
0.87
Shares outstanding
172.83M
No. of employees
797
News stories
From web sources and news partners
GuruFocus
·
10 hours ago
ACAD Maintained by Morgan Stanley -- Price Target Lowered to $24
TradingView
·
21 hours ago
Key facts: ACAD Price Target Slips to $30.33; Analysts Maintain Buy
TradingView
·
22 hours ago
ACADIA Pharmaceuticals Inc. Stock 12‑Month Price Target Cut to $30.33, Implies 67% Upside
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteacadia.com